• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯并环烷衍生物作为褪黑素受体新型构象受限配体的合成

Synthesis of benzocycloalkane derivatives as new conformationally restricted ligands for melatonin receptors.

作者信息

Kloubert S, Mathé-Allainmat M, Andrieux J, Sicsic S, Langlois M

机构信息

CNRS-BIOCIS (URA 1843), Université de Paris-Sud, Faculté de Pharmacie, Châtenay-Malabry, France.

出版信息

Bioorg Med Chem Lett. 1998 Dec 1;8(23):3325-30. doi: 10.1016/s0960-894x(98)00601-5.

DOI:10.1016/s0960-894x(98)00601-5
PMID:9873728
Abstract

Benzocycloalkane derivatives 1-4 were synthesized as new conformationally restricted melatoninergic ligands. They were prepared by the reaction of the ketones 5 with diethylcyanophosphonate and the reduction of the corresponding cyano compounds or by the Wittig reaction and Curtius degradation to obtain the amines 8. The 1-Cyanobenzocyclobutane derivative was obtained by the benzyne cyclisation reaction. The amines 8 were acylated with acetyl, propionyl or butyryl groups. The affinity of the compounds for chicken brain melatonin receptors was evaluated using 2-[125I]-iodomelatonin as the radioligand. The indanyl (2b,c), tetralin (3a-c) and benzocycloheptane (4c) derivatives were potent compounds with nanomolar affinity and an important enantioselectivity of the receptor was observed with the (+) enantiomers 2b and 3b.

摘要

苯并环烷衍生物1-4被合成为新型构象受限的褪黑素能配体。它们通过酮5与氰基磷酸二乙酯的反应以及相应氰基化合物的还原反应制备,或者通过维蒂希反应和库尔提斯降解反应来获得胺8。1-氰基苯并环丁烷衍生物通过苯炔环化反应制得。胺8用乙酰基、丙酰基或丁酰基进行酰化。使用2-[¹²⁵I]-碘褪黑素作为放射性配体评估了这些化合物对鸡脑褪黑素受体的亲和力。茚满基(2b,c)、四氢萘基(3a-c)和苯并环庚烷(4c)衍生物是具有纳摩尔亲和力的强效化合物,并且观察到(+)对映体2b和3b对受体具有重要的对映选择性。

相似文献

1
Synthesis of benzocycloalkane derivatives as new conformationally restricted ligands for melatonin receptors.苯并环烷衍生物作为褪黑素受体新型构象受限配体的合成
Bioorg Med Chem Lett. 1998 Dec 1;8(23):3325-30. doi: 10.1016/s0960-894x(98)00601-5.
2
Melatonergic properties of the (+)- and (-)-enantiomers of N-(4-methoxy-2,3-dihydro-1H-phenalen-2-yl)amide derivatives.N-(4-甲氧基-2,3-二氢-1H-菲-2-基)酰胺衍生物的(+)-和(-)-对映体的褪黑素能特性
J Med Chem. 1999 Mar 25;42(6):1100-5. doi: 10.1021/jm9804937.
3
Synthesis of phenalene and acenaphthene derivatives as new conformationally restricted ligands for melatonin receptors.菲烯和苊衍生物的合成作为褪黑素受体新的构象受限配体
J Med Chem. 2000 Nov 2;43(22):4051-62. doi: 10.1021/jm000922c.
4
Synthesis of new arylalkoxy amido derivatives as melatoninergic ligands.
Bioorg Med Chem. 2003 Mar 6;11(5):789-800. doi: 10.1016/s0968-0896(02)00328-0.
5
Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.2-酰胺基-2,3-二氢-1H-菲衍生物的合成:作为褪黑素受体新型构象受限配体
J Med Chem. 1996 Aug 2;39(16):3089-95. doi: 10.1021/jm960219h.
6
Synthesis of beta-substituted naphth-1-yl ethylamido derivatives as new melatoninergic agonists.新型褪黑素能激动剂β-取代萘-1-基乙酰胺衍生物的合成
Bioorg Med Chem. 1999 Dec;7(12):2945-52. doi: 10.1016/s0968-0896(99)00236-9.
7
Synthesis of a small library of phenylalkylamide derivatives as melatoninergic ligands for human mt1 and MT2 receptors.
Bioorg Med Chem. 2000 Jan;8(1):163-71. doi: 10.1016/s0968-0896(99)00285-0.
8
Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study.褪黑素受体配体:新型褪黑素衍生物的合成及比较分子力场分析(CoMFA)综合研究
J Med Chem. 1998 Sep 24;41(20):3831-44. doi: 10.1021/jm9810093.
9
Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3).对褪黑素能结合位点MT(3)具有高亲和力和选择性的硝基吲哚衍生物的合成。
J Med Chem. 2002 Apr 25;45(9):1853-9. doi: 10.1021/jm011053+.
10
The high affinity melationin binding site probed with conformationally restricted ligand--I. Pharmacophore and minireceptor models.
Bioorg Med Chem. 1996 Aug;4(8):1321-32. doi: 10.1016/0968-0896(96)00113-7.